{"schema_version":"secwatch.filing_event.v1","accession":"0001156039-24-000119","form_type":"8-K","ticker":"ELV","cik":"0001156039","company_name":"Elevance Health, Inc.","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.798715+00:00","generated_at":"2026-05-30T13:02:21.822344+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Elevance Health Q3 adjusted EPS $8.37; FY2024 guidance cut to ~$33.00","bullets":["Q3 2024 operating revenue $44.7B, up $2.2B YoY; diluted EPS $4.36 GAAP, adjusted $8.37.","Benefit expense ratio 89.5%, up 270 bps driven by Medicaid rate-acuity mismatch; operating margin 3.1% (adj 5.3%).","Medical membership ~45.8M, down 1.5M (3%) due to Medicaid attrition and footprint adjustments.","Board authorized $8.0B increase to share repurchase program; Q4 dividend $1.63/share declared.","FY2024 GAAP EPS guidance ~$26.50, adjusted EPS ~$33.00, reflecting Medicaid headwinds."],"urls":{"canonical":"https://secwatch.observer/filing/0001156039-24-000119","json":"https://secwatch.observer/filing/0001156039-24-000119.json","markdown":"https://secwatch.observer/filing/0001156039-24-000119.md","text":"https://secwatch.observer/filing/0001156039-24-000119.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/0001156039-24-000119-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1156039/000115603924000119/elv-20241017.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:02:21.822344+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}